Daniel Boffa, MD

• Abhijit Patel
• Andre Levchenko
• Anna Shlionsky Bader
• Anne Chiang
• Benjamin L. Judson
• Cary Gross
• Christopher Gange
• David Rimm
• Dhanpat Jain
• Dirk C Johnson
• Gavitt Woodard
• Harriet Kluger
• Henry S. Park
• Jason L. Schwartz
• Jill Lacy
• John Elefteriades
• John Morton
• Joseph Ross
• Jun Lu
• Katerina Politi
• Kelly Olino
• Kerin Adelson
• Kevin Billingsley
• Kimberly Davis
• Lynn D. Wilson
• Lynn Tanoue
• Margaret Pisani
• Mario Sznol
• Michael Cecchini
• Michael S. Leapman
• Naftali Kaminski
• Pamela L. Kunz
• Patrick A. Kenney
• Robert Homer
• Roy S. Herbst
• Sajid A Khan
• Scott Gettinger
• Stacey Stein
• Wanda Popescu
• Zuoheng Anita Wang

Medical Oncology

• Telehealth Availability for Cancer Care During the COVID-19 Pandemic: Cross-Sectional StudyMarks V, Hsiang W, Nie J, Umer W, Haleem A, Galal B, Pak I, Kim D, Salazar M, Pantel H, Berger E, Boffa D, Cavallo J, Leapman M. Telehealth Availability for Cancer Care During the COVID-19 Pandemic: Cross-Sectional Study. JMIR Cancer 2023, 9: e45518. PMID: 37917149, PMCID: PMC10654905, DOI: 10.2196/45518.
• Impact of the COVID-19 Pandemic on Lung Cancer Screening Processes in a Northeast Tertiary Health Care NetworkUdelsman B, Detterbeck F, Tanoue L, Mase V, Boffa D, Blasberg J, Dhanasopon A, Ely S, Mazzarelli L, Bader A, Woodard G. Impact of the COVID-19 Pandemic on Lung Cancer Screening Processes in a Northeast Tertiary Health Care Network. Journal Of Computer Assisted Tomography 2023, 48: 222-225. PMID: 37832536, DOI: 10.1097/rct.0000000000001549.
• Brief Report: Increasing Prevalence of Ground-Glass Nodules and Semisolid Lung Lesions on Outpatient Chest Computed Tomography ScansWoodard G, Udelsman B, Prince S, Blasberg J, Dhanasopon A, Gange C, Traube L, Mase V, Boffa D, Detterbeck F, Bader A. Brief Report: Increasing Prevalence of Ground-Glass Nodules and Semisolid Lung Lesions on Outpatient Chest Computed Tomography Scans. JTO Clinical And Research Reports 2023, 4: 100583. PMID: 38074773, PMCID: PMC10709040, DOI: 10.1016/j.jtocrr.2023.100583.
• Alterations in Cancer Treatment During the First Year of the COVID-19 Pandemic in the USJanczewski L, Cotler J, Merkow R, Palis B, Nelson H, Mullett T, Boffa D. Alterations in Cancer Treatment During the First Year of the COVID-19 Pandemic in the US. JAMA Network Open 2023, 6: e2340148. PMID: 37902756, PMCID: PMC10616721, DOI: 10.1001/jamanetworkopen.2023.40148.
• Respect the Middle Lobe: Perioperative Risk of Bilobectomy Compared With Lobectomy and PneumonectomyLi A, Canavan M, Ermer T, Maduka R, Zhan P, Pichert M, Boffa D, Blasberg J. Respect the Middle Lobe: Perioperative Risk of Bilobectomy Compared With Lobectomy and Pneumonectomy. The Annals Of Thoracic Surgery 2023, 117: 163-171. PMID: 37774762, DOI: 10.1016/j.athoracsur.2023.09.023.
• Association of Wildfire Exposure While Recovering From Lung Cancer Surgery With Overall SurvivalZhang D, Xi Y, Boffa D, Liu Y, Nogueira L. Association of Wildfire Exposure While Recovering From Lung Cancer Surgery With Overall Survival. JAMA Oncology 2023, 9: 1214-1220. PMID: 37498574, PMCID: PMC10375383, DOI: 10.1001/jamaoncol.2023.2144.
• Assessment of a collaborative treatment model for trimodal management of esophageal cancerUdelsman B, Ermer T, Ely S, Canavan M, Zhan P, Boffa D, Blasberg J. Assessment of a collaborative treatment model for trimodal management of esophageal cancer. Journal Of Thoracic Disease 2023, 15: 4668-4680. PMID: 37868899, PMCID: PMC10586936, DOI: 10.21037/jtd-23-346.
• ASO Visual Abstract: The Representation of Surgery in Oncology Clinical Trials: 2001–2022Shah R, Boffa D, Khan S, Judson B. ASO Visual Abstract: The Representation of Surgery in Oncology Clinical Trials: 2001–2022. Annals Of Surgical Oncology 2023, 30: 7325-7326. DOI: 10.1245/s10434-023-14125-8.
• The Representation of Surgery in Oncology Clinical Trials: 2001 to 2022Shah R, Boffa D, Khan S, Judson B. The Representation of Surgery in Oncology Clinical Trials: 2001 to 2022. Annals Of Surgical Oncology 2023, 30: 7275-7280. PMID: 37556010, DOI: 10.1245/s10434-023-14064-4.
• Overall survival in low-comorbidity patients with stage I non–small cell lung cancer who chose stereotactic body radiotherapy compared to surgeryUdelsman B, Canavan M, Zhan P, Ely S, Park H, Boffa D, Mase V. Overall survival in low-comorbidity patients with stage I non–small cell lung cancer who chose stereotactic body radiotherapy compared to surgery. Journal Of Thoracic And Cardiovascular Surgery 2023, 167: 822-833.e7. PMID: 37500052, DOI: 10.1016/j.jtcvs.2023.07.021.
• Disruption of National Cancer Database Data Models in the First Year of the COVID-19 PandemicLum S, Browner A, Palis B, Nelson H, Boffa D, Nogueira L, Hawhee V, McCabe R, Mullett T, Wick E. Disruption of National Cancer Database Data Models in the First Year of the COVID-19 Pandemic. JAMA Surgery 2023, 158: 643-650. PMID: 37043215, DOI: 10.1001/jamasurg.2023.0652.
• Effect of pandemic-related reductions in cancer care delivery on different US health systems.Janczewski L, Cotler J, Merkow R, Palis B, Nelson H, Mullett T, Boffa D. Effect of pandemic-related reductions in cancer care delivery on different US health systems. Journal Of Clinical Oncology 2023, 41: e18811-e18811. DOI: 10.1200/jco.2023.41.16_suppl.e18811.
• The Growth of Medical Knowledge and Data SharingBoffa D, Nelson H, Shulman L. The Growth of Medical Knowledge and Data Sharing. JAMA 2023, 329: 1314-1315. PMID: 37071103, DOI: 10.1001/jama.2023.2345.
• ASO Visual Abstract: Association Between Metastatic Pattern and Prognosis in Stage IV Gastric Cancer—Potential for Stage Classification ReformZhan P, Canavan M, Ermer T, Pichert M, Li A, Maduka R, Udelsman B, Nemeth A, Boffa D. ASO Visual Abstract: Association Between Metastatic Pattern and Prognosis in Stage IV Gastric Cancer—Potential for Stage Classification Reform. Annals Of Surgical Oncology 2023, 30: 4192-4192. DOI: 10.1245/s10434-023-13397-4.
• Association Between Metastatic Pattern and Prognosis in Stage IV Gastric Cancer: Potential for Stage Classification ReformZhan P, Canavan M, Ermer T, Pichert M, Li A, Maduka R, Udelsman B, Nemeth A, Boffa D. Association Between Metastatic Pattern and Prognosis in Stage IV Gastric Cancer: Potential for Stage Classification Reform. Annals Of Surgical Oncology 2023, 30: 4180-4191. PMID: 36869917, DOI: 10.1245/s10434-023-13287-9.
• Off-Pump Methacrylate Cement Pulmonary EmbolectomyUdelsman B, Credaroli E, Notarianni A, Elefteriades J, Boffa D, Popescu W. Off-Pump Methacrylate Cement Pulmonary Embolectomy. Annals Of Thoracic Surgery Short Reports 2023, 1: 49-51. DOI: 10.1016/j.atssr.2022.09.001.
• ASO Visual Abstract: Evaluation of the Impact of the COVID-19 Pandemic on Reliability of Cancer Surveillance Data in the National Cancer DatabaseNogueira L, Palis B, Boffa D, Lum S, Yabroff K, Nelson H. ASO Visual Abstract: Evaluation of the Impact of the COVID-19 Pandemic on Reliability of Cancer Surveillance Data in the National Cancer Database. Annals Of Surgical Oncology 2023, 30: 2094-2094. PMCID: PMC9869810, DOI: 10.1245/s10434-022-13022-w.
• Evaluation of the Impact of the COVID-19 Pandemic on Reliability of Cancer Surveillance Data in the National Cancer DatabaseNogueira L, Palis B, Boffa D, Lum S, Yabroff K, Nelson H. Evaluation of the Impact of the COVID-19 Pandemic on Reliability of Cancer Surveillance Data in the National Cancer Database. Annals Of Surgical Oncology 2022, 30: 2087-2093. PMID: 36539579, PMCID: PMC9767395, DOI: 10.1245/s10434-022-12935-w.
• Utilization and Outcomes of Radiation in Stage IV Esophageal CancerZhan P, Canavan M, Ermer T, Pichert M, Li A, Maduka R, Kaminski M, Johung K, Boffa D. Utilization and Outcomes of Radiation in Stage IV Esophageal Cancer. JTO Clinical And Research Reports 2022, 3: 100429. PMID: 36483656, PMCID: PMC9722471, DOI: 10.1016/j.jtocrr.2022.100429.
• Thoracic CT follow-up after non-small-cell lung cancer resectionWoodard G, Boffa D, Blasberg J. Thoracic CT follow-up after non-small-cell lung cancer resection. The Lancet Oncology 2022, 23: e484. PMID: 36328013, DOI: 10.1016/s1470-2045(22)00618-0.
• Cancer of the LungMorgensztern D, Boffa D, Chen A, Dhanasopon A, Goldberg S, Decker R, Devarakonda S, Ko J, Soto L, Waqar S, Wistuba I, Herbst R. Cancer of the Lung. 2022, 1-29. DOI: 10.1002/9781119000822.hfcm085.pub2.
• Nonregional Lymph Nodes as the Only Metastatic Site in Stage IV Esophageal CancerZhan P, Canavan M, Ermer T, Pichert M, Li A, Maduka R, Kaminski M, Boffa D. Nonregional Lymph Nodes as the Only Metastatic Site in Stage IV Esophageal Cancer. JTO Clinical And Research Reports 2022, 3: 100426. PMID: 36444359, PMCID: PMC9700291, DOI: 10.1016/j.jtocrr.2022.100426.
• OA11.03 Nonregional Lymph Nodes as the Only Metastatic Site in Stage IV Non-Small Cell Lung Cancer: A Marker of Better PrognosisZhan P, Canavan M, Ermer T, Pichert M, Li A, Maduka R, Kaminski M, Boffa D. OA11.03 Nonregional Lymph Nodes as the Only Metastatic Site in Stage IV Non-Small Cell Lung Cancer: A Marker of Better Prognosis. Journal Of Thoracic Oncology 2022, 17: s29-s30. DOI: 10.1016/j.jtho.2022.07.056.
• Evaluating information loss in the National Cancer Database from cases lost to follow‐upCotler JH, Nogueira L, McCabe R, Nelson H, Brajcich BC, Boffa DJ, Lum SS, Harris JB, Hawhee V, Mullett TW, Bilimoria KY, Palis BE. Evaluating information loss in the National Cancer Database from cases lost to follow‐up. Journal Of Surgical Oncology 2022, 126: 1123-1132. PMID: 36029288, DOI: 10.1002/jso.26977.
• Immunotherapy After Chemotherapy and Radiation for Clinical Stage III Lung CancerPichert MD, Canavan ME, Maduka RC, Li AX, Ermer T, Zhan PL, Kaminski M, Udelsman BV, Blasberg JD, Park HS, Goldberg SB, Boffa DJ. Immunotherapy After Chemotherapy and Radiation for Clinical Stage III Lung Cancer. JAMA Network Open 2022, 5: e2224478. PMID: 35925606, PMCID: PMC9353596, DOI: 10.1001/jamanetworkopen.2022.24478.
• Acceptance of Simulated Adult Patients With Medicaid Insurance Seeking Care in a Cancer Hospital for a New Cancer DiagnosisMarks VA, Hsiang WR, Nie J, Demkowicz P, Umer W, Haleem A, Galal B, Pak I, Kim D, Salazar MC, Berger ER, Boffa DJ, Leapman MS. Acceptance of Simulated Adult Patients With Medicaid Insurance Seeking Care in a Cancer Hospital for a New Cancer Diagnosis. JAMA Network Open 2022, 5: e2222214. PMID: 35838668, PMCID: PMC9287756, DOI: 10.1001/jamanetworkopen.2022.22214.
• Association of Lymph Node Sampling and Clinical Volume in Lobectomy for Non–Small Cell Lung CancerUdelsman BV, Chang DC, Boffa DJ, Gaissert HA. Association of Lymph Node Sampling and Clinical Volume in Lobectomy for Non–Small Cell Lung Cancer. The Annals Of Thoracic Surgery 2022, 115: 166-173. PMID: 35752354, DOI: 10.1016/j.athoracsur.2022.05.051.
• Evaluation of gastroesophageal reflux disease and hiatal hernia as risk factors for lobectomy complicationsKaminski MF, Ermer T, Canavan M, Li AX, Maduka RC, Zhan P, Boffa DJ, Case MD. Evaluation of gastroesophageal reflux disease and hiatal hernia as risk factors for lobectomy complications. JTCVS Open 2022, 11: 327-345. PMID: 36172441, PMCID: PMC9510864, DOI: 10.1016/j.xjon.2022.05.017.
• Association of Insurance Status and Extent of Organ Involvement With Survival Among Patients With Stage IV CancerZhan PL, Canavan ME, Ermer T, Pichert MD, Li AX, Maduka RC, Boffa DJ. Association of Insurance Status and Extent of Organ Involvement With Survival Among Patients With Stage IV Cancer. JAMA Network Open 2022, 5: e2217581. PMID: 35713907, PMCID: PMC9206181, DOI: 10.1001/jamanetworkopen.2022.17581.
• Association Between Food and Drug Administration Approval and Disparities in Immunotherapy Use Among Patients With Cancer in the USErmer T, Canavan ME, Maduka RC, Li AX, Salazar MC, Kaminski MF, Pichert MD, Zhan PL, Mase V, Kluger H, Boffa DJ. Association Between Food and Drug Administration Approval and Disparities in Immunotherapy Use Among Patients With Cancer in the US. JAMA Network Open 2022, 5: e2219535. PMID: 35771575, PMCID: PMC9247736, DOI: 10.1001/jamanetworkopen.2022.19535.
• Defining Relevancy in Patient-Reported Outcomes for Lung Cancer SurgeryDhanasopon AP, Boffa DJ. Defining Relevancy in Patient-Reported Outcomes for Lung Cancer Surgery. Annals Of Surgical Oncology 2022, 29: 5367-5368. PMID: 35503390, DOI: 10.1245/s10434-022-11797-6.
• Revisiting Indications for Brain Imaging During the Clinical Staging Evaluation of Lung CancerPichert MD, Canavan ME, Maduka RC, Li AX, Ermer T, Zhan PL, Kaminski M, Udelsman BV, Blasberg JD, Mase VJ, Dhanasopon AP, Boffa DJ. Revisiting Indications for Brain Imaging During the Clinical Staging Evaluation of Lung Cancer. JTO Clinical And Research Reports 2022, 3: 100318. PMID: 35540711, PMCID: PMC9079298, DOI: 10.1016/j.jtocrr.2022.100318.
• 109MO Respect the middle lobe: Perioperative survival of bilobectomy compared to lobectomy and pneumonectomyLi A, Canavan M, Ermer T, Kaminski M, Maduka R, Zhan P, Flores K, Boffa D, Blasberg J. 109MO Respect the middle lobe: Perioperative survival of bilobectomy compared to lobectomy and pneumonectomy. Annals Of Oncology 2022, 33: s82. DOI: 10.1016/j.annonc.2022.02.136.
• Appendiceal Cancer in the National Cancer Database: Increasing Frequency, Decreasing Age, and Shifting Histology.Salazar MC, Canavan ME, Chilakamarry S, Boffa DJ, Schuster KM. Appendiceal Cancer in the National Cancer Database: Increasing Frequency, Decreasing Age, and Shifting Histology. Journal Of The American College Of Surgeons 2022, 234: 1082-1089. PMID: 35703801, DOI: 10.1097/xcs.0000000000000172.
• Nonadherence to Multimodality Cancer Treatment Guidelines in the United StatesTchelebi LT, Shen B, Wang M, Potters L, Herman J, Boffa D, Segel JE, Park HS, Zaorsky NG. Nonadherence to Multimodality Cancer Treatment Guidelines in the United States. Advances In Radiation Oncology 2022, 7: 100938. PMID: 35469182, PMCID: PMC9034283, DOI: 10.1016/j.adro.2022.100938.
• Access to High-Volume Hospitals for High-Risk Cancer Surgery for Racial and Ethnic Minoritized GroupsSalazar MC, Canavan ME, Holaday LW, Billingsley KG, Ross J, Boffa DJ, Gross CP. Access to High-Volume Hospitals for High-Risk Cancer Surgery for Racial and Ethnic Minoritized Groups. JNCI Cancer Spectrum 2022, 6: pkac024. PMID: 35603855, PMCID: PMC8997114, DOI: 10.1093/jncics/pkac024.
• Understanding the Implications of Medicaid Expansion for Cancer Care in the USErmer T, Walters SL, Canavan ME, Salazar MC, Li AX, Doonan M, Boffa DJ. Understanding the Implications of Medicaid Expansion for Cancer Care in the US. JAMA Oncology 2022, 8: 139-148. PMID: 34762101, DOI: 10.1001/jamaoncol.2021.4323.
• Privacy-Preserving Data Sharing for Medical ResearchFischer M, Hochman J, Boffa D. Privacy-Preserving Data Sharing for Medical Research. 2021, 13046: 78-89. DOI: 10.1007/978-3-030-91081-5_6.
• Pre-Operative Chemoradiotherapy With or Without Induction Chemotherapy for Operable Locally-Advanced Esophageal CancerPeters G, Wang S, Peters N, Dhanasopan A, Lacy J, Cecchini M, Kortmansky J, Stein S, Kunz P, Lattanzi S, Park H, Boffa D, Johung K, Jethwa K. Pre-Operative Chemoradiotherapy With or Without Induction Chemotherapy for Operable Locally-Advanced Esophageal Cancer. International Journal Of Radiation Oncology • Biology • Physics 2021, 111: e68. DOI: 10.1016/j.ijrobp.2021.07.422.
• Twenty-Five Years of Cancer Follow-Up; Is the Data Worth the Effort?Brajcich BC, Palis BE, McCabe R, Nogueira L, Boffa DJ, Lum SS, Harris JB, Hawhee V, Mullett TW, Bilimoria KY, Nelson H. Twenty-Five Years of Cancer Follow-Up; Is the Data Worth the Effort? Annals Of Surgical Oncology 2021, 29: 828-836. PMID: 34689251, DOI: 10.1245/s10434-021-10668-w.
• ASO Visual Abstract: Twenty-Five Years of Cancer Follow-Up: Are the Data Worth the Effort?Brajcich B, Palis B, McCabe R, Nogueira L, Boffa D, Lum S, Harris J, Hawhee V, Mullett T, Bilimoria K, Nelson H. ASO Visual Abstract: Twenty-Five Years of Cancer Follow-Up: Are the Data Worth the Effort? Annals Of Surgical Oncology 2021, 28: 674-675. DOI: 10.1245/s10434-021-10738-z.
• Baseline Evaluation of Cancer Mortality in US States that Expanded Medicaid vs Nonexpansion StatesSalazar MC, Kaminski MF, Canavan ME, Maduka RC, Li AX, Ermer T, Boffa DJ. Baseline Evaluation of Cancer Mortality in US States that Expanded Medicaid vs Nonexpansion States. JAMA Oncology 2021, 7: 1394-1395. PMID: 34292299, PMCID: PMC8299357, DOI: 10.1001/jamaoncol.2021.2582.
• Diversity, Equity, and Representativeness: Coming to Terms With the Henrietta Lacks Act.Boffa DJ, Churchwell KB, Maduka RC. Diversity, Equity, and Representativeness: Coming to Terms With the Henrietta Lacks Act. Journal Of The National Comprehensive Cancer Network 2021, 19: 993-996. PMID: 34416709, DOI: 10.6004/jnccn.2021.7071.
• Role of adjuvant therapy in T1-2N0 resected non–small cell lung cancerWoodard GA, Li A, Boffa DJ. Role of adjuvant therapy in T1-2N0 resected non–small cell lung cancer. Journal Of Thoracic And Cardiovascular Surgery 2021, 163: 1685-1692. PMID: 34334172, DOI: 10.1016/j.jtcvs.2021.05.053.
• Trends in Patient Volume by Hospital Type and the Association of These Trends With Time to Cancer Treatment InitiationFrosch ZAK, Illenberger N, Mitra N, Boffa DJ, Facktor MA, Nelson H, Palis BE, Bekelman JE, Shulman LN, Takvorian SU. Trends in Patient Volume by Hospital Type and the Association of These Trends With Time to Cancer Treatment Initiation. JAMA Network Open 2021, 4: e2115675. PMID: 34241630, PMCID: PMC8271360, DOI: 10.1001/jamanetworkopen.2021.15675.
• Optimal Radiation Dose for Stage III Lung Cancer—Should “Definitive” Radiation Doses Be Used in the Preoperative Setting?Saffarzadeh AG, Canavan M, Resio BJ, Walters SL, Flores KM, Decker RH, Boffa DJ. Optimal Radiation Dose for Stage III Lung Cancer—Should “Definitive” Radiation Doses Be Used in the Preoperative Setting? JTO Clinical And Research Reports 2021, 2: 100201. PMID: 34590044, PMCID: PMC8474436, DOI: 10.1016/j.jtocrr.2021.100201.
• Randomized Phase II Study of PET Response–Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) TrialGoodman KA, Ou FS, Hall NC, Bekaii-Saab T, Fruth B, Twohy E, Meyers MO, Boffa DJ, Mitchell K, Frankel WL, Niedzwiecki D, Noonan A, Janjigian YY, Thurmes PJ, Venook AP, Meyerhardt JA, O'Reilly EM, Ilson DH. Randomized Phase II Study of PET Response–Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial. Journal Of Clinical Oncology 2021, 39: 2803-2815. PMID: 34077237, PMCID: PMC8407649, DOI: 10.1200/jco.20.03611.
• Outcomes of surgically managed primary lung sarcomas: a National Cancer Database analysisLi AX, Resio BJ, Canavan ME, Papageorge M, Boffa DJ, Blasberg JD. Outcomes of surgically managed primary lung sarcomas: a National Cancer Database analysis. Journal Of Thoracic Disease 2021, 0: 0-0. PMID: 34277037, PMCID: PMC8264694, DOI: 10.21037/jtd-21-1.
• Change in facility-level share of Medicaid patients with cancer following implementation of the affordable care act.Buck M, Demkowicz P, Nie J, Marks V, Salazar M, Kenney P, Boffa D, Leapman M. Change in facility-level share of Medicaid patients with cancer following implementation of the affordable care act. Journal Of Clinical Oncology 2021, 39: e18543-e18543. DOI: 10.1200/jco.2021.39.15_suppl.e18543.
• Adjuvant Chemotherapy for T4 Non-Small Cell Lung Cancer with Additional Ipsilateral Lung NodulesLi AX, Flores K, Canavan ME, Boffa DJ, Blasberg JD. Adjuvant Chemotherapy for T4 Non-Small Cell Lung Cancer with Additional Ipsilateral Lung Nodules. The Annals Of Thoracic Surgery 2021, 113: 421-428. PMID: 33684345, DOI: 10.1016/j.athoracsur.2021.02.042.
• Adjuvant Chemotherapy in Patients With Early-Stage Non–Small Cell Lung Cancer—ReplyPathak R, Boffa DJ. Adjuvant Chemotherapy in Patients With Early-Stage Non–Small Cell Lung Cancer—Reply. JAMA Oncology 2021, 7: 638-638. PMID: 33630034, DOI: 10.1001/jamaoncol.2020.8194.
• The Survival Advantage of Lobectomy over Wedge Resection Lessens as Health-Related Life Expectancy DecreasesSalazar MC, Canavan ME, Walters SL, Chilakamarry S, Ermer T, Blasberg JD, Yu JB, Gross CP, Boffa DJ. The Survival Advantage of Lobectomy over Wedge Resection Lessens as Health-Related Life Expectancy Decreases. JTO Clinical And Research Reports 2021, 2: 100143. PMID: 34590002, PMCID: PMC8474228, DOI: 10.1016/j.jtocrr.2021.100143.
• Chemoradiation as a nonsurgical treatment option for early-stage esophageal cancers: a retrospective cohort studyPathak R, Canavan ME, Walters S, Salazar MC, Boffa DJ. Chemoradiation as a nonsurgical treatment option for early-stage esophageal cancers: a retrospective cohort study. Journal Of Thoracic Disease 2021, 13: 140-148. PMID: 33569194, PMCID: PMC7867841, DOI: 10.21037/jtd-20-1187.
• Commentary: Go big or stay home?Chilakamarry S, Boffa DJ. Commentary: Go big or stay home? Journal Of Thoracic And Cardiovascular Surgery 2020, 161: 1711-1712. PMID: 33514472, DOI: 10.1016/j.jtcvs.2020.12.083.
• Costs Associated With Lobectomy for Lung Cancer: An Analysis Merging STS and Medicare DataMedbery RL, Fernandez FG, Kosinski AS, Tong BC, Furnary AP, Feng L, Onaitis M, Boffa D, Wright CD, Cowper P, Jacobs JP, Putnam JB, Habib RH. Costs Associated With Lobectomy for Lung Cancer: An Analysis Merging STS and Medicare Data. The Annals Of Thoracic Surgery 2020, 111: 1781-1790. PMID: 33188754, DOI: 10.1016/j.athoracsur.2020.08.073.
• A National Study of Surgically Managed Atypical Pulmonary Carcinoid TumorsWalters SL, Canavan ME, Salazar MC, Resio BJ, Blasberg JD, Mase V, Boffa DJ. A National Study of Surgically Managed Atypical Pulmonary Carcinoid Tumors. The Annals Of Thoracic Surgery 2020, 112: 921-927. PMID: 33159862, DOI: 10.1016/j.athoracsur.2020.09.029.
• Association of Survival With Adjuvant Chemotherapy Among Patients With Early-Stage Non–Small Cell Lung Cancer With vs Without High-Risk Clinicopathologic FeaturesPathak R, Goldberg SB, Canavan M, Herrin J, Hoag JR, Salazar MC, Papageorge M, Ermer T, Boffa DJ. Association of Survival With Adjuvant Chemotherapy Among Patients With Early-Stage Non–Small Cell Lung Cancer With vs Without High-Risk Clinicopathologic Features. JAMA Oncology 2020, 6: 1741-1750. PMID: 32940636, PMCID: PMC7499246, DOI: 10.1001/jamaoncol.2020.4232.
• Consensus for Thoracoscopic Left Upper Lobectomy—Essential Components and Targets for SimulationBryan DS, Ferguson MK, Antonoff MB, Backhus LM, Birdas TJ, Blackmon SH, Boffa DJ, Chang AC, Chmielewski GW, Cooke DT, Donington JS, Gaissert HA, Hagen JA, Hofstetter WL, Kent MS, Kim KW, Krantz SB, Lin J, Martin LW, Meyerson SL, Mitchell JD, Molena D, Odell DD, Onaitis MW, Puri V, Putnam JB, Seder CW, Shrager JB, Soukiasian HJ, Stiles BM, Tong BC, Veeramachaneni NK. Consensus for Thoracoscopic Left Upper Lobectomy—Essential Components and Targets for Simulation. The Annals Of Thoracic Surgery 2020, 112: 436-442. PMID: 33127408, DOI: 10.1016/j.athoracsur.2020.06.152.
• Results of COVID-minimal Surgical Pathway During Surge-phase of COVID-19 PandemicBoffa DJ, Judson BL, Billingsley KG, Del Rossi E, Hindinger K, Walters S, Ermer T, Ratner E, Mitchell MR, Laurans MS, Johnson DC, Yoo PS, Morton JM, Zurich HB, Davis K, Ahuja N. Results of COVID-minimal Surgical Pathway During Surge-phase of COVID-19 Pandemic. Annals Of Surgery 2020, 272: e316-e320. PMID: 33086321, PMCID: PMC7668334, DOI: 10.1097/sla.0000000000004455.
• Intestinal metaplasia around the gastroesophageal junction is frequently associated with antral reactive gastropathy: implications for carcinoma at the gastroesophageal junctionVyas M, Celli R, Singh M, Patel N, Aslanian HR, Boffa D, Deng Y, Ciarleglio MM, Laine L, Jain D. Intestinal metaplasia around the gastroesophageal junction is frequently associated with antral reactive gastropathy: implications for carcinoma at the gastroesophageal junction. Human Pathology 2020, 105: 67-73. PMID: 32941964, DOI: 10.1016/j.humpath.2020.08.007.
• ASO Author Reflections: Complex Cancer Surgery Mortality After 30 Days: An Opportunity for ImprovementResio BJ, Boffa DJ. ASO Author Reflections: Complex Cancer Surgery Mortality After 30 Days: An Opportunity for Improvement. Annals Of Surgical Oncology 2020, 28: 1287-1288. PMID: 32901307, DOI: 10.1245/s10434-020-09083-4.
• Where the Other Half Dies: Analysis of Mortalities Occurring More Than 30 Days After Complex Cancer SurgeryResio BJ, Gonsalves L, Canavan M, Mueller L, Phillips C, Sathe T, Swett K, Boffa DJ. Where the Other Half Dies: Analysis of Mortalities Occurring More Than 30 Days After Complex Cancer Surgery. Annals Of Surgical Oncology 2020, 28: 1278-1286. PMID: 32885398, DOI: 10.1245/s10434-020-09080-7.
• Evaluation of Cancer Care After Medicaid Expansion Under the Affordable Care ActSalazar MC, Canavan ME, Walters SL, Herrin J, Schwartz JL, Leapman M, Boffa DJ. Evaluation of Cancer Care After Medicaid Expansion Under the Affordable Care Act. JAMA Network Open 2020, 3: e2017544. PMID: 32990734, PMCID: PMC7525361, DOI: 10.1001/jamanetworkopen.2020.17544.
• Navigating by Stars: Using CMS Star Ratings to Choose Hospitals for Complex Cancer SurgeryPapageorge MV, Resio BJ, Monsalve AF, Canavan M, Pathak R, Mase VJ, Dhanasopon AP, Hoag JR, Blasberg JD, Boffa DJ. Navigating by Stars: Using CMS Star Ratings to Choose Hospitals for Complex Cancer Surgery. JNCI Cancer Spectrum 2020, 4: pkaa059-. PMID: 33134834, PMCID: PMC7583163, DOI: 10.1093/jncics/pkaa059.
• Association of Programmed Cell Death Ligand 1 Expression Status With Receipt of Immune Checkpoint Inhibitors in Patients With Advanced Non–Small Cell Lung CancerLeapman MS, Presley CJ, Zhu W, Soulos PR, Adelson KB, Miksad RA, Boffa DJ, Gross CP. Association of Programmed Cell Death Ligand 1 Expression Status With Receipt of Immune Checkpoint Inhibitors in Patients With Advanced Non–Small Cell Lung Cancer. JAMA Network Open 2020, 3: e207205. PMID: 32511721, PMCID: PMC7280954, DOI: 10.1001/jamanetworkopen.2020.7205.
• Association of hospital type and patient volume growth with timely cancer treatment.Frosch Z, Illenberger N, Mitra N, Boffa D, Facktor M, Nelson H, Bekelman J, Shulman L, Takvorian S. Association of hospital type and patient volume growth with timely cancer treatment. Journal Of Clinical Oncology 2020, 38: 2022-2022. DOI: 10.1200/jco.2020.38.15_suppl.2022.
• Pandemic Recovery Using a COVID-Minimal Cancer Surgery PathwayBoffa DJ, Judson BL, Billingsley KG, Galetta D, Fontanez P, Odermatt C, Lindner K, Mitchell MR, Henderson CM, Carafeno T, Pinto J, Wagner J, Ancuta M, Beley P, Turner AL, Banack T, Laurans MS, Johnson DC, Yoo P, Morton JM, Zurich H, Davis K, Ahuja N. Pandemic Recovery Using a COVID-Minimal Cancer Surgery Pathway. The Annals Of Thoracic Surgery 2020, 110: 718-724. PMID: 32417195, PMCID: PMC7227551, DOI: 10.1016/j.athoracsur.2020.05.003.
• Persistent Pleural Air Leak Due to Metastatic Basal Cell CarcinomaRamayanam S, Boffa D, Thakore S, Puchalski J. Persistent Pleural Air Leak Due to Metastatic Basal Cell Carcinoma. 2020, a5896-a5896. DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a5896.
• Survival After Cancer Treatment at Top-Ranked US Cancer Hospitals vs Affiliates of Top-Ranked Cancer HospitalsBoffa DJ, Mallin K, Herrin J, Resio B, Salazar MC, Palis B, Facktor M, McCabe R, Nelson H, Shulman LN. Survival After Cancer Treatment at Top-Ranked US Cancer Hospitals vs Affiliates of Top-Ranked Cancer Hospitals. JAMA Network Open 2020, 3: e203942. PMID: 32453382, PMCID: PMC7251445, DOI: 10.1001/jamanetworkopen.2020.3942.
• Invasive Staging Procedures Do Not Prevent Nodal Metastases From Being Missed in Stage I Lung CancerResio BJ, Canavan M, Mase V, Dhanasopon AP, Blasberg JD, Boffa DJ. Invasive Staging Procedures Do Not Prevent Nodal Metastases From Being Missed in Stage I Lung Cancer. The Annals Of Thoracic Surgery 2020, 110: 390-397. PMID: 32283084, DOI: 10.1016/j.athoracsur.2020.03.026.
• COVID-19 Guidance for Triage of Operations for Thoracic Malignancies: A Consensus Statement From Thoracic Surgery Outcomes Research NetworkNetwork I, Antonoff M, Backhus L, Boffa D, Broderick S, Brown L, Carrott P, Clark J, Cooke D, David E, Facktor M, Farjah F, Grogan E, Isbell J, Jones D, Kidane B, Kim A, Keshavjee S, Krantz S, Lui N, Martin L, Meguid R, Meyerson S, Mullett T, Nelson H, Odell D, Phillips J, Puri V, Rusch V, Shulman L, Varghese T, Wakeam E, Wood D. COVID-19 Guidance for Triage of Operations for Thoracic Malignancies: A Consensus Statement From Thoracic Surgery Outcomes Research Network. The Annals Of Thoracic Surgery 2020, 110: 692-696. PMID: 32278755, PMCID: PMC7146713, DOI: 10.1016/j.athoracsur.2020.03.005.
• COVID-19 guidance for triage of operations for thoracic malignancies: A consensus statement from Thoracic Surgery Outcomes Research NetworkNetwork I, Antonoff M, Backhus L, Boffa DJ, Broderick SR, Brown LM, Carrott P, Clark JM, Cooke D, David E, Facktor M, Farjah F, Grogan E, Isbell J, Jones DR, Kidane B, Kim AW, Keshavjee S, Krantz S, Lui N, Martin L, Meguid RA, Meyerson SL, Mullett T, Nelson H, Odell DD, Phillips JD, Puri V, Rusch V, Shulman L, Varghese TK, Wakeam E, Wood DE. COVID-19 guidance for triage of operations for thoracic malignancies: A consensus statement from Thoracic Surgery Outcomes Research Network. Journal Of Thoracic And Cardiovascular Surgery 2020, 160: 601-605. PMID: 32689703, PMCID: PMC7146695, DOI: 10.1016/j.jtcvs.2020.03.061.
• 3:18 PM Abstract No. 148 Current United States nationwide utilization of thermal ablation for lung cancerUhlig J, Case M, Gettinger S, Blasberg J, Boffa D, Kim K. 3:18 PM Abstract No. 148 Current United States nationwide utilization of thermal ablation for lung cancer. Journal Of Vascular And Interventional Radiology 2020, 31: s70. DOI: 10.1016/j.jvir.2019.12.182.
• Abstract No. 520 Stage 4 lung cancer: comparison of thermal ablation and stereotactic body radiotherapy for the pulmonary primaryUhlig J, Case M, Gettinger S, Blasberg J, Boffa D, Kim K. Abstract No. 520 Stage 4 lung cancer: comparison of thermal ablation and stereotactic body radiotherapy for the pulmonary primary. Journal Of Vascular And Interventional Radiology 2020, 31: s227-s228. DOI: 10.1016/j.jvir.2019.12.581.
• Surgeon's Perspective to Local Therapy in Oligometastatic Cancer.Boffa DJ. Surgeon's Perspective to Local Therapy in Oligometastatic Cancer. The Cancer Journal 2020, 26: 149-155. PMID: 32205540, DOI: 10.1097/ppo.0000000000000441.
• Equivalent Survival Between Lobectomy and Segmentectomy for Clinical Stage IA Lung CancerOnaitis MW, Furnary AP, Kosinski AS, Feng L, Boffa D, Tong BC, Cowper P, Jacobs JP, Wright CD, Habib R, Putnam JB, Fernandez FG. Equivalent Survival Between Lobectomy and Segmentectomy for Clinical Stage IA Lung Cancer. The Annals Of Thoracic Surgery 2020, 110: 1882-1891. PMID: 32119855, DOI: 10.1016/j.athoracsur.2020.01.020.
• Surgically Managed Signet Ring Cell Esophageal Carcinomas in the National Cancer DatabaseSathe TS, Resio BJ, Hoag JR, Monsalve AF, Pathak R, Blasberg JD, Mase V, Dhanasopon A, Boffa DJ. Surgically Managed Signet Ring Cell Esophageal Carcinomas in the National Cancer Database. The Annals Of Thoracic Surgery 2020, 109: 1656-1662. PMID: 32109449, DOI: 10.1016/j.athoracsur.2020.01.021.
• Commentary: The majority of minoritiesSalazar MC, Boffa DJ. Commentary: The majority of minorities. Journal Of Thoracic And Cardiovascular Surgery 2020, 160: 272-273. PMID: 32033814, DOI: 10.1016/j.jtcvs.2019.12.067.
• Commentary: How surprisingBoffa DJ, Salazar M. Commentary: How surprising. Journal Of Thoracic And Cardiovascular Surgery 2019, 159: 2483-2484. PMID: 32033820, DOI: 10.1016/j.jtcvs.2019.11.118.
• Single-cell connectomic analysis of adult mammalian lungsRaredon MSB, Adams TS, Suhail Y, Schupp JC, Poli S, Neumark N, Leiby KL, Greaney AM, Yuan Y, Horien C, Linderman G, Engler AJ, Boffa DJ, Kluger Y, Rosas IO, Levchenko A, Kaminski N, Niklason LE. Single-cell connectomic analysis of adult mammalian lungs. Science Advances 2019, 5: eaaw3851. PMID: 31840053, PMCID: PMC6892628, DOI: 10.1126/sciadv.aaw3851.
• Can the Centers for Medicare and Medicaid Star Ratings Be Used as a Realistic Approach to Reduce Mortality in Complex Cancer Surgery?Papageorge M, Hoag J, Resio B, Monsalve A, Pathak R, Mase V, Dhanasopon A, Blasberg J, Boffa D. Can the Centers for Medicare and Medicaid Star Ratings Be Used as a Realistic Approach to Reduce Mortality in Complex Cancer Surgery? Journal Of The American College Of Surgeons 2019, 229: s144. DOI: 10.1016/j.jamcollsurg.2019.08.319.
• P2.17-07 Role of Adjuvant Chemotherapy After Sublobar Resection in Stage I NSCLCPathak R, Goldberg S, Hoag J, Monsalve A, Resio B, Papageorge M, Boffa D. P2.17-07 Role of Adjuvant Chemotherapy After Sublobar Resection in Stage I NSCLC. Journal Of Thoracic Oncology 2019, 14: s886. DOI: 10.1016/j.jtho.2019.08.1918.
• Digital Inference of Immune Microenvironment Reveals Low-Risk Subtype of Early Lung AdenocarcinomaKurbatov V, Balayev A, Saffarzadeh A, Heller DR, Boffa DJ, Blasberg JD, Lu J, Khan SA. Digital Inference of Immune Microenvironment Reveals Low-Risk Subtype of Early Lung Adenocarcinoma. The Annals Of Thoracic Surgery 2019, 109: 343-349. PMID: 31568747, DOI: 10.1016/j.athoracsur.2019.08.050.
• The Society of Thoracic Surgeons General Thoracic Surgery Database: 2019 Update on ResearchCrabtree TD, Boffa DJ, Lobdell KW, Habib RH, Gaissert HA. The Society of Thoracic Surgeons General Thoracic Surgery Database: 2019 Update on Research. The Annals Of Thoracic Surgery 2019, 108: 1293-1298. PMID: 31520641, DOI: 10.1016/j.athoracsur.2019.09.001.
• Variations in Surgical Safety According to Affiliation Status With a Top-Ranked Cancer HospitalResio BJ, Hoag JR, Chiu AS, Monsalve A, Sathe T, Xu X, Boffa DJ. Variations in Surgical Safety According to Affiliation Status With a Top-Ranked Cancer Hospital. JAMA Oncology 2019, 5: 1359-1362. PMID: 31294746, PMCID: PMC6624807, DOI: 10.1001/jamaoncol.2019.1808.
• Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non–Small Cell Lung CancerUhlig J, Case MD, Blasberg JD, Boffa DJ, Chiang A, Gettinger SN, Kim HS. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non–Small Cell Lung Cancer. JAMA Network Open 2019, 2: e199702. PMID: 31433481, PMCID: PMC6707019, DOI: 10.1001/jamanetworkopen.2019.9702.
• Regionalization of esophagectomy: where are we now?Clark JM, Boffa DJ, Meguid RA, Brown LM, Cooke DT. Regionalization of esophagectomy: where are we now? Journal Of Thoracic Disease 2019, 1: s1633-s1642. PMID: 31489231, PMCID: PMC6702400, DOI: 10.21037/jtd.2019.07.88.
• Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanomaKlemen ND, Wang M, Feingold PL, Cooper K, Pavri SN, Han D, Detterbeck FC, Boffa DJ, Khan SA, Olino K, Clune J, Ariyan S, Salem RR, Weiss SA, Kluger HM, Sznol M, Cha C. Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanoma. Journal For ImmunoTherapy Of Cancer 2019, 7: 196. PMID: 31340861, PMCID: PMC6657062, DOI: 10.1186/s40425-019-0672-3.
• Endoscopic versus Open Vein-Graft Harvesting for CABG.Saffarzadeh A, Hoag JR, Boffa DJ. Endoscopic versus Open Vein-Graft Harvesting for CABG. New England Journal Of Medicine 2019, 380: e43. PMID: 31141649, DOI: 10.1056/nejmc1904533.
• Benefit of combining local treatment and systemic therapy for stage IV NSCLC: Results from the National Cancer Database.Dendy Case M, Uhlig J, Blasberg J, Boffa D, Chiang A, Gettinger S, Kim H. Benefit of combining local treatment and systemic therapy for stage IV NSCLC: Results from the National Cancer Database. Journal Of Clinical Oncology 2019, 37: 8545-8545. DOI: 10.1200/jco.2019.37.15_suppl.8545.
• Refining the role of adjuvant chemotherapy in stage IB and IIA NSCLC.Pathak R, Hoag J, Goldberg S, Monsalve A, Resio B, Boffa D. Refining the role of adjuvant chemotherapy in stage IB and IIA NSCLC. Journal Of Clinical Oncology 2019, 37: 8519-8519. DOI: 10.1200/jco.2019.37.15_suppl.8519.
• Real-world practice patterns and impact of PD-L1 expression testing in patients with advanced non-small cell lung cancer.Leapman M, Presley C, Zhu W, Soulos P, Adelson K, Boffa D, Gross C. Real-world practice patterns and impact of PD-L1 expression testing in patients with advanced non-small cell lung cancer. Journal Of Clinical Oncology 2019, 37: 9059-9059. DOI: 10.1200/jco.2019.37.15_suppl.9059.
• Cross-Species scRNAseq Systems Biology Analysis of Cell-Cell Signaling in LungRaredon M, Adams T, Schupp J, Suhail Y, Leiby K, Greaney A, Boffa D, Levchenko A, Kaminski N, Niklason L. Cross-Species scRNAseq Systems Biology Analysis of Cell-Cell Signaling in Lung. 2019, a6073-a6073. DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a6073.
• Sternotomy for aortic dissection with substernal pull through: The importance of surgical historyPichert M, Mori M, Boffa DJ, Mangi AA. Sternotomy for aortic dissection with substernal pull through: The importance of surgical history. Journal Of Thoracic And Cardiovascular Surgery 2019, 159: e325-e326. PMID: 31350021, DOI: 10.1016/j.jtcvs.2019.04.038.
• Differential Safety Between Top-Ranked Cancer Hospitals and Their Affiliates for Complex Cancer SurgeryHoag JR, Resio BJ, Monsalve AF, Chiu AS, Brown LB, Herrin J, Blasberg JD, Kim AW, Boffa DJ. Differential Safety Between Top-Ranked Cancer Hospitals and Their Affiliates for Complex Cancer Surgery. JAMA Network Open 2019, 2: e191912. PMID: 30977848, PMCID: PMC6481444, DOI: 10.1001/jamanetworkopen.2019.1912.
• Prophylactic cranial irradiation is associated with improved survival following resection for limited stage small cell lung cancerResio BJ, Hoag J, Chiu A, Monsalve A, Dhanasopon AP, Boffa DJ, Blasberg JD. Prophylactic cranial irradiation is associated with improved survival following resection for limited stage small cell lung cancer. Journal Of Thoracic Disease 2019, 11: 811-818. PMID: 31019769, PMCID: PMC6462708, DOI: 10.21037/jtd.2019.01.64.
• Corrigendum to ‘Delayed discharge does not decrease the cost of readmission after pulmonary lobectomy’ [Surgery 164/6 (2018) 1294–1299]Jean RA, Chiu AS, Boffa DJ, Detterbeck FC, Kim AW, Blasberg JD. Corrigendum to ‘Delayed discharge does not decrease the cost of readmission after pulmonary lobectomy’ [Surgery 164/6 (2018) 1294–1299]. Surgery 2019, 165: 1058. PMID: 30678871, DOI: 10.1016/j.surg.2018.12.014.
• What’s Lost in What’s Missing: A Thoughtful Approach to Missing Data in the National Cancer DatabaseBoffa DJ. What’s Lost in What’s Missing: A Thoughtful Approach to Missing Data in the National Cancer Database. Annals Of Surgical Oncology 2019, 26: 709-710. PMID: 30603815, DOI: 10.1245/s10434-018-07130-9.
• Variable impact of prior cancer history on the survival of lung cancer patientsMonsalve AF, Hoag JR, Resio BJ, Chiu AS, Brown LB, Detterbeck FC, Blasberg JD, Boffa DJ. Variable impact of prior cancer history on the survival of lung cancer patients. Lung Cancer 2018, 127: 130-137. PMID: 30642541, DOI: 10.1016/j.lungcan.2018.11.040.
• Lack of correlation between short- and long-term performance after lung cancer surgeryFernandez FG, Kosinski AS, Tong BC, Furnary AP, Feng L, Onaitis M, Boffa D, Wright CD, Cowper P, Jacobs JP, Habib RH, Putnam JB. Lack of correlation between short- and long-term performance after lung cancer surgery. Journal Of Thoracic And Cardiovascular Surgery 2018, 157: 1633-1643.e3. PMID: 30635179, DOI: 10.1016/j.jtcvs.2018.09.141.
• Survival outcomes from CALGB 80803 (Alliance): A randomized phase II trial of PET scan-directed combined modality therapy for esophageal cancer.Goodman K, Hall N, Bekaii-Saab T, Ou F, Twohy E, Meyers M, Boffa D, Mitchell K, Perry K, Frankel W, Venook A, O'Reilly E, Ilson D. Survival outcomes from CALGB 80803 (Alliance): A randomized phase II trial of PET scan-directed combined modality therapy for esophageal cancer. Journal Of Clinical Oncology 2018, 36: 4012-4012. DOI: 10.1200/jco.2018.36.15_suppl.4012.
• Using the National Cancer Database for Outcomes Research: A ReviewBoffa DJ, Rosen JE, Mallin K, Loomis A, Gay G, Palis B, Thoburn K, Gress D, McKellar DP, Shulman LN, Facktor MA, Winchester DP. Using the National Cancer Database for Outcomes Research: A Review. JAMA Oncology 2017, 3: 1722-1728. PMID: 28241198, DOI: 10.1001/jamaoncol.2016.6905.
• 1341P Assessing response to immunotherapy in patients with non-small cell lung cancer using circulating tumor DNAGoldberg S, Narayan A, Kole A, Decker R, Teysir J, Carriero N, Lee A, Nemati R, Nath S, Mane S, Deng Y, Sukumar N, Zelterman D, Boffa D, Politi K, Gettinger S, Wilson L, Herbst R, Patel A. 1341P Assessing response to immunotherapy in patients with non-small cell lung cancer using circulating tumor DNA. Annals Of Oncology 2017, 28: v478. DOI: 10.1093/annonc/mdx380.043.
• Effectiveness of local therapy for stage I non–small-cell lung cancer in nonagenariansArnold BN, Thomas DC, Rosen JE, Salazar MC, Detterbeck FC, Blasberg JD, Boffa DJ, Kim AW. Effectiveness of local therapy for stage I non–small-cell lung cancer in nonagenarians. Surgery 2017, 162: 640-651. PMID: 28697883, DOI: 10.1016/j.surg.2017.04.025.
• The impact of tumor size on survival in T3 non-small cell lung-cancer with direct extension.Kim C, Salazar M, Hoag J, Rosen J, Arnold B, Boffa D, Blasberg J. The impact of tumor size on survival in T3 non-small cell lung-cancer with direct extension. Journal Of Clinical Oncology 2017, 35: e20033-e20033. DOI: 10.1200/jco.2017.35.15_suppl.e20033.
• Indications for Invasive Mediastinal Staging in Patients with Early Non–Small Cell Lung Cancer Staged with Positron Emission Tomography-Computed TomographyGao S, Kim A, Puchalski J, Bramley K, Detterbeck F, Boffa D, Decker R. Indications for Invasive Mediastinal Staging in Patients with Early Non–Small Cell Lung Cancer Staged with Positron Emission Tomography-Computed Tomography. International Journal Of Radiation Oncology • Biology • Physics 2017, 98: 223. DOI: 10.1016/j.ijrobp.2017.01.061.
• Initial results of CALGB 80803 (Alliance): A randomized phase II trial of PET scan-directed combined modality therapy for esophageal cancer.Goodman K, Niedzwiecki D, Hall N, Bekaii-Saab T, Ye X, Meyers M, Mitchell-Richards K, Boffa D, Frankel W, Venook A, Hochster H, Crane C, O'Reilly E, Ilson D. Initial results of CALGB 80803 (Alliance): A randomized phase II trial of PET scan-directed combined modality therapy for esophageal cancer. Journal Of Clinical Oncology 2017, 35: 1-1. DOI: 10.1200/jco.2017.35.4_suppl.1.
• P1.05-017 The Prognostic Impact of EGFR, KRAS and TP53 Somatic Mutations in Curatively Resected Early-Stage Lung Adenocarcinomas Topic: Translational Research and BiomarkersRothberg B, Das R, Jackson L, Lazowski H, Bai Y, O'Neill D, Roberts S, Rothberg J, Herbst R, Kim A, Boffa D, Rimm D, Detterbeck F, Tanoue L. P1.05-017 The Prognostic Impact of EGFR, KRAS and TP53 Somatic Mutations in Curatively Resected Early-Stage Lung Adenocarcinomas Topic: Translational Research and Biomarkers. Journal Of Thoracic Oncology 2017, 12: s623-s624. DOI: 10.1016/j.jtho.2016.11.801.
• Organization, Teamwork and Quality of Care in Thoracic Surgery A Model for High Reliability Care Delivery.Detterbeck FC, Zurich HB, Agarwal R, Blasberg JD, Boffa DJ, Delrossi EP, Finan ME, Hindinger KK, Kim AW, Pierson M. Organization, Teamwork and Quality of Care in Thoracic Surgery A Model for High Reliability Care Delivery. Connecticut Medicine 2017, 81: 5-12. PMID: 29782759.
• Defining outcomes of patients with clinical stage I small cell lung cancer upstaged at surgeryThomas DC, Arnold BN, Rosen JE, Salazar MC, Blasberg JD, Detterbeck FC, Boffa DJ, Kim AW. Defining outcomes of patients with clinical stage I small cell lung cancer upstaged at surgery. Lung Cancer 2016, 103: 75-81. PMID: 28024700, DOI: 10.1016/j.lungcan.2016.11.016.
• The Eighth Edition Lung Cancer Stage ClassificationDetterbeck FC, Boffa DJ, Kim AW, Tanoue LT. The Eighth Edition Lung Cancer Stage Classification. CHEST Journal 2016, 151: 193-203. PMID: 27780786, DOI: 10.1016/j.chest.2016.10.010.
• Role of Adjuvant Therapy for Node-Negative Lung Cancer Invading the Chest WallGao SJ, Corso CD, Blasberg JD, Detterbeck FC, Boffa DJ, Decker RH, Kim AW. Role of Adjuvant Therapy for Node-Negative Lung Cancer Invading the Chest Wall. Clinical Lung Cancer 2016, 18: 169-177.e4. PMID: 27890561, DOI: 10.1016/j.cllc.2016.08.005.
• Timing of Surgery After Neoadjuvant Chemoradiation in Clinical Stage IIIA Non-Small Cell Lung Cancer With Mediastinal Nodal InvolvementGao S, Corso C, Wang E, Blasberg J, Boffa D, Detterbeck F, Kim A. Timing of Surgery After Neoadjuvant Chemoradiation in Clinical Stage IIIA Non-Small Cell Lung Cancer With Mediastinal Nodal Involvement. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: e470. DOI: 10.1016/j.ijrobp.2016.06.1811.
• Effects of Adjuvant Therapy on Survival in T3N0 Non-Small Cell Lung Cancer Invading the Chest WallGao S, Corso C, Detterbeck F, Boffa D, Decker R, Kim A. Effects of Adjuvant Therapy on Survival in T3N0 Non-Small Cell Lung Cancer Invading the Chest Wall. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: s68-s69. DOI: 10.1016/j.ijrobp.2016.06.175.
• Indications for Invasive Mediastinal Staging in Patients With Early Non-Small Cell Lung Cancer Staged With Positron Emission Tomography/Computed TomographyGao S, Kim A, Detterbeck F, Boffa D, Puchalski J, Decker R. Indications for Invasive Mediastinal Staging in Patients With Early Non-Small Cell Lung Cancer Staged With Positron Emission Tomography/Computed Tomography. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: s11. DOI: 10.1016/j.ijrobp.2016.06.041.
• 75P PD-L1 expression on circulating CD45(-) cells is an independent prognostic factor for overall survival (OS) in patients (Pts) across all stages of treatment-naïve lung cancer in a prospective, multicenter studyGraf R, Lu D, Krupa R, Louw J, Dugan L, Jendrisak A, Orr S, Bethel K, Wang Y, Suraneni M, Landers M, Boffa D, Nieva J, Bazhenova L, Salazar M, Makani S, Magana M, Dittamore R. 75P PD-L1 expression on circulating CD45(-) cells is an independent prognostic factor for overall survival (OS) in patients (Pts) across all stages of treatment-naïve lung cancer in a prospective, multicenter study. Annals Of Oncology 2016, 27: vi22. DOI: 10.1093/annonc/mdw363.23.
• The differential impact of preoperative comorbidity on perioperative outcomes following thoracoscopic and open lobectomiesJawitz OK, Wang Z, Boffa DJ, Detterbeck FC, Blasberg JD, Kim AW. The differential impact of preoperative comorbidity on perioperative outcomes following thoracoscopic and open lobectomies. European Journal Of Cardio-Thoracic Surgery 2016, 51: 169-174. PMID: 27458143, DOI: 10.1093/ejcts/ezw239.
• Programmed cell death-1 ligand (PD-L1) expression on circulating CD45(-) cells is an independent prognostic factor for overall survival in patients (Pts) with lung cancer in a prospective, multicenter cohort.Boffa D, Nieva J, Bazhenova L, Krupa R, Lu D, Graf R, Louw J, Dugan L, Jendrisak A, Salazar M, Makani S, Magana M, Orr S, Bethel K, Wang Y, Marrinucci D, Dittamore R. Programmed cell death-1 ligand (PD-L1) expression on circulating CD45(-) cells is an independent prognostic factor for overall survival in patients (Pts) with lung cancer in a prospective, multicenter cohort. Journal Of Clinical Oncology 2016, 34: 8524-8524. DOI: 10.1200/jco.2016.34.15_suppl.8524.
• Transcervical Wedge Resection after Transcervical Extended Mediastinal LymphadenectomyKim A, Kull D, Zieliński M, Boffa D, Detterbeck F. Transcervical Wedge Resection after Transcervical Extended Mediastinal Lymphadenectomy. Innovations Technology And Techniques In Cardiothoracic And Vascular Surgery 2014, 9: 327-329. DOI: 10.1177/155698451400900413.
• Learning Curve to Lymph Node Resection in Minimally Invasive Esophagectomy for CancerDhamija A, Rosen J, Dhamija A, Rothberg B, Kim A, Detterbeck F, Boffa D. Learning Curve to Lymph Node Resection in Minimally Invasive Esophagectomy for Cancer. Innovations Technology And Techniques In Cardiothoracic And Vascular Surgery 2014, 9: 286-291. DOI: 10.1177/155698451400900405.
• Postoperative chemotherapy as effective as preoperative for N2-positive stage III non-small cell lung cancer.Boffa D, Hancock J, Moreno A, Rosen J, Kim A, Detterbeck F. Postoperative chemotherapy as effective as preoperative for N2-positive stage III non-small cell lung cancer. Journal Of Clinical Oncology 2014, 32: 7533-7533. DOI: 10.1200/jco.2014.32.15_suppl.7533.
• Detection of sensitizing and resistance EGFR mutations from circulating tumor DNA (ctDNA) in blood using multiplexed next-generation sequencing in patients with advanced EGFR -mutant lung adenocarcinoma.Goldberg S, Narayan A, Carriero N, Nemati R, Bommakanti A, Wurtz A, Boffa D, Decker R, Herbst R, Juergensmeier J, Politi K, Gettinger S, Patel A. Detection of sensitizing and resistance EGFR mutations from circulating tumor DNA (ctDNA) in blood using multiplexed next-generation sequencing in patients with advanced EGFR -mutant lung adenocarcinoma. Journal Of Clinical Oncology 2014, 32: 8093-8093. DOI: 10.1200/jco.2014.32.15_suppl.8093.
• Experience with Thoracoscopic Pneumonectomies at a Single InstitutionKim A, Fonseca A, Boffa D, Detterbeck F. Experience with Thoracoscopic Pneumonectomies at a Single Institution. Innovations Technology And Techniques In Cardiothoracic And Vascular Surgery 2014, 9: 82-86. DOI: 10.1177/155698451400900202.
• Influence of Ground-glass Opacities on the Diagnostic Evaluation of Patients with Multiple Lung CancersHall M, Maxfield M, Krechman A, Oliva I, Homer R, Boffa D, Detterbeck F, Kim A. Influence of Ground-glass Opacities on the Diagnostic Evaluation of Patients with Multiple Lung Cancers. Journal Of Surgical Research 2014, 186: 494. DOI: 10.1016/j.jss.2013.11.025.
• Endobronchial Treatment of Pulsatile Hemoptysis Complicating Y-Stent Management of TracheobronchomalaciaRyu C, Bramley K, Boffa D, Pisani M, Puchalski J. Endobronchial Treatment of Pulsatile Hemoptysis Complicating Y-Stent Management of Tracheobronchomalacia. CHEST Journal 2013, 144: 46a-46b. DOI: 10.1378/chest.1698542.
• F-089MINIMALLY INVASIVE OESOPHAGECTOMY MORE EXPENSIVE THAN OPEN AT NORTH AMERICAN HOSPITAL DESPITE SHORTER LENGTH OF STAYDhamija A, Dhamija A, Kim A, Detterbeck F, Boffa D. F-089MINIMALLY INVASIVE OESOPHAGECTOMY MORE EXPENSIVE THAN OPEN AT NORTH AMERICAN HOSPITAL DESPITE SHORTER LENGTH OF STAY. Interdisciplinary CardioVascular And Thoracic Surgery 2013, 17: s24-s24. DOI: 10.1093/icvts/ivt288.89.
• Impact of Preoperative Radiation on Survival of Patients With Node Negative, Very Large Non-small Cell Lung Cancers (T3N0) Treated With Anatomic ResectionMoreno A, Morgensztern D, Yu J, Boffa D, Decker R, Detterbeck F, Kim A. Impact of Preoperative Radiation on Survival of Patients With Node Negative, Very Large Non-small Cell Lung Cancers (T3N0) Treated With Anatomic Resection. Journal Of Surgical Research 2013, 179: 283. DOI: 10.1016/j.jss.2012.10.554.
• Technetium to Localize Small or Ground Glass Pulmonary Nodules for VATS ResectionDhamija A, Reiner E, Rubinowitz A, Guo X, Finan M, Kim A, Detterbeck F, Boffa D. Technetium to Localize Small or Ground Glass Pulmonary Nodules for VATS Resection. CHEST Journal 2012, 142: 54a-54b. DOI: 10.1378/chest.1389841.
• Expanding The Role For Endobronchial Valves: Empyema-Induced "Bronchocutaneous" FistulaeBritto C, Johnson K, Boffa D, Puchalski J. Expanding The Role For Endobronchial Valves: Empyema-Induced "Bronchocutaneous" Fistulae. 2012, a5196-a5196. DOI: 10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a5196.
• Abstract 349: Fascin expression in colorectal cancer metastases predicts survival after curative-intent surgerySullivan C, Guo X, Wang Z, Theoharis C, Rimm D, Boffa D. Abstract 349: Fascin expression in colorectal cancer metastases predicts survival after curative-intent surgery. Cancer Research 2011, 71: 349-349. DOI: 10.1158/1538-7445.am2011-349.
• Abstract 2234: Circulating tumor cells are rare in patients with curable oligometastatic cancerBoffa D, Guo X, Molinaro A, Finan B, Detterbeck F, Rimm D. Abstract 2234: Circulating tumor cells are rare in patients with curable oligometastatic cancer. Cancer Research 2010, 70: 2234-2234. DOI: 10.1158/1538-7445.am10-2234.
• P6 Decortication after lung transplantationBoffa D, Mason D, Murthy S, Pettersson B. P6 Decortication after lung transplantation. Journal Of Surgical Research 2007, 137: 243. DOI: 10.1016/j.jss.2006.12.233.
• Celiac Lymph Nodes and Esophageal CancerRice T, Boffa D. Celiac Lymph Nodes and Esophageal Cancer. 2007, 271-278. DOI: 10.1007/978-1-84628-474-8_33.